| Issuer | % of Class | Filed |
|---|---|---|
|
Tenax Therapeutics, Inc.
13D/A
Amendment 1
TENX · 88032L605
|
4.3% |
7/31/2026
Event 7/31/2026
|
|
Tenax Therapeutics, Inc.
13D
TENX · 88032L605
|
6.8% |
3/10/2026
Event 12/10/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.